By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Verona Pharma 

Suite 21 - Alpha House
100 Borough High Street
London    SE1 1LB  United Kingdom
Phone: 44-0-20-7863-3300 Fax: 44-0-20-7863-3314



Life Sciences

Company News
Verona Pharma (VRP.L) Plans To Conduct Registered Initial Public Offering In The U.S. 11/23/2016 1:54:34 PM
Verona Pharma (VRP.L) Rakes in $63.3 Million to Help Progress COPD Candidate RPL554 6/21/2016 6:11:21 AM
Verona Pharma (VRP.L) Announces Positive Results From "Add-On" Phase II Trial With RPL554 5/10/2016 11:06:30 AM
Verona Pharma (VRP.L) Release: Paper Demonstrating That RPL554 Enhances CTFR Activation In Cystic Fibrosis Airway Epithelia Published In American Journal Of Physiology 11/11/2015 10:06:02 AM
Verona Pharma (VRP.L) Release: Completion Of Patient Enrolment In Two RPL554 Phase IIa Studies, Ahead Of Expected Timeline 11/5/2015 11:29:25 AM
Verona Pharma (VRP.L) Presents At BIO-Europe Partnering Conference 11/3/2015 9:24:12 AM
Verona Pharma (VRP.L) Announces Start Of RPL554 Phase IIa Combination Study 10/14/2015 11:22:11 AM
Verona Pharma (VRP.L) Data Demonstrating PDE3/4 Inhibitor RPL554 Enhances CTFR-Dependent Currents In Cystic Fibrosis Airway Epithelia 10/8/2015 10:17:09 AM
Verona Pharma (VRP.L) Positive Headline Data From RPL554 Clinical Study In COPD Patients 9/29/2015 9:36:04 AM
Verona Pharma (VRP.L) Appoints Dr Ken Cunningham And Dr Anders Ullman As Non-Executive Directors 9/8/2015 10:51:28 AM